Outcome of BRCA1- compared with BRCA2-associated ovarian cancer: a nationwide study in the Netherlands
P.M.L.H. Vencken(Erasmus MC), Caroline Seynaeve(Radboud University Nijmegen), B.F.M. Slangen(Maastricht University Medical Centre), Marjanka K. Schmidt(University of Cambridge), Hans F. A. Vasen(Leiden University Medical Center), Joanne A. de Hullu(Radboud University Nijmegen), Mieke Kriege, Welmoed Reitsma(University Medical Center Groningen), Marc van Beurden(Oncode Institute), Ronald P. Zweemer(Cancer Genomics Centre), Geertruida H. de Bock(University Medical Center Groningen), Anne M. van Altena(Radboud University Nijmegen), Muriel A. Adank(The Netherlands Cancer Institute), Curt W. Burger, Katja N. Gaarenstroom(Radboud University Nijmegen), Fem Rijcken, Marian J.E. Mourits(Radboud University Nijmegen)
Cited by 22
Related Papers
Efficacy of MRI and Mammography for Breast-Cancer Screening in Women with a Familial or Genetic Predisposition
|New England Journal of Medicine|2004|1.7k
Association analysis identifies 65 new breast cancer risk loci
|Nature|2017|1.6k
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes
|The American Journal of Human Genetics|2018|1.2k
Large-scale genotyping identifies 41 new loci associated with breast cancer risk
|Nature Genetics|2013|1.1k